Evidence-Based Psychedelic Medicine Company Harmoniously.com to Join Leading Health Care Conference

Extended Plant Medicine Retreats are Designed for Deep Personal Evolution in the Jungle of Peru

Maya will be the outcomes data capture platform for veterans undergoing psychedelic treatments funded by Heroic Hearts Project. Maya will simultaneously be deployed with related organizations, The Mission Within, Heroic Path to Light, and The Hope Project. Combined, this partnership will generate the largest structured dataset illustrating health outcomes of psychedelic treatments for veterans and their family members.

Green Bay Packers Quarterback Aaron Rodgers and other professional athletes share thoughts on reducing stigma and encourage others to pursue healing with plant-based medicine.

Study will investigate possible links between Hallucinogen Persisting Perception Disorder and anxiety.

CaaMTech will help carry on Dr. Alexander Shulgin's legacy by developing ASRI's novel compounds

Offering the most accessible ketamine solution on the market, the holistic telehealth protocol is now available to eligible patients in CA, NY, FL and TX following initial $4.6 million raised in seed funding.

Tripsitter.com Becomes the Ultimate Crash Course on Psychedelics After Publishing 100 Psychedelic Monographs in 2022 Upgrade

Dr. Peter Silverstone breaks down the complex topic of psychedelics as a treatment for mental health

Dr. Peter Silverstone breaks down the complex topic of psychedelics as a treatment for mental health

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech

Scientists will assess the potential of psychedelic compounds for treating addiction

Woven Science's El Puente foundation is pleased to release for public comment its policy paper and corporate social responsibility initiative for psychedelic pharmaceutical companies to engage with indigenous peoples using psychedelic botanicals in traditional practice. This paper explores how public policymakers in collaboration with companies can offer indigenous communities influence over product development, consumer preferences, profit sharing, and public perception.

The investment provides CaaMTech with capital to advance compounds from its library into clinical trials

The First-Ever Women-Focused Psychedelic Healthcare Company

Woven Science is the first company to take a holistic approach to mental wellbeing through psychedelic models of care, while putting a system of reciprocity towards indigenous communities at the core of its business.

More than $1M in Capital Deployed through Platform
More than 1,000 Psychedelic Companies Tracked
200-Page Industry Research Report Included for Investors

CaaMTech's first of over one hundred patent applications is nearing the finish line

Next Generation of Impact-Driven Psychedelic and Psychedelic-Adjacent Entrepreneurs and Start-ups to Receive Needed Resources and Mentorship

The Manke Lab at UMass Dartmouth is a global leader in novel tryptamine synthesis and characterization

The collaborative research aims to fill several gaps in the scientific understanding of the chemical composition of psychedelic psilocybin-containing mushrooms

Recipients to Be Awarded with Mentorship, Access to Influencers and Other Resources

Startups, Researchers, Artists, Non-profits, Activists and Influencers to Define the Future of the Psychedelic Ecosystem

Recipients to Be Awarded with Mentorship, Access to Influencers and Other Resources

The Designer Drug Research Unit at the National Institute on Drug Abuse will conduct research on CaaMTech's library of tryptamine-based compounds

ebbu Founder & CEO led the company's C $429M exit to Canopy Growth